Pepticom

PepticomPepticom
Pepticom

Pepticom

AI platform for accelerating novel peptide therapeutic discovery and development.

DR 252011Inactive16Jerusalem, Israel
Rate

About

Pepticom utilizes a unique Artificial Intelligence (AI) platform to accelerate and optimize the discovery of novel peptide therapeutics. Their technology, based on research from the Hebrew University, aims to overcome limitations in traditional drug discovery by efficiently identifying and designing peptide candidates.
Frequently asked

What does Pepticom do?

Pepticom utilizes a unique Artificial Intelligence (AI) platform to accelerate and optimize the discovery of novel peptide therapeutics. Their technology, based on research from the Hebrew University, aims to overcome limitations in traditional drug discovery by efficiently identifying and designing peptide candidates.

What is Pepticom's revenue?

StartupHub estimates Pepticom's annual revenue at $3.0M (range $1.6M to $5.5M, 67% confidence), based on comparable companies in the sector.

What is Pepticom's valuation?

StartupHub estimates Pepticom's effective valuation at $31.0M (range $19.0M to $45.6M, 10% confidence), based on comparable companies in the sector.

How much funding has Pepticom raised?

Pepticom has raised a total of $8M in funding. The most recent round on record is Funding Round.

Where is Pepticom headquartered?

Pepticom is headquartered in Jerusalem, Israel.

When was Pepticom founded?

Pepticom was founded in 2011.

What industry does Pepticom operate in?

Pepticom operates in Healthcare, Drug Discovery, Clinical Development, Peptide Drugs, Life Sciences, Biotech.

How many employees does Pepticom have?

Pepticom has approximately 16 people on record.

What is Pepticom's current status?

Pepticom's current operating status is: Inactive.

HEADCOUNT
16
DOMAIN RATING
25
Comments

No comments yet. Be the first to share your take.